CAM
SRRA

Cormorant Asset Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Cormorant Asset Management’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,329
Closed -$358K – 93
2016
Q1 		$358K Hold
1,329
– – 0.05% 79
2015
Q4 		$799K Hold
1,329
– – 0.1% 72
2015
Q3 		$1.09M Buy
+1,329
New +$1.5M 0.17% 70

Other funds holding SRRA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GT
Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

Cormorant Asset Management's SRRA Position: Q2 2016 in Review

Cormorant Asset Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q2 2016, closing a stake of 1,329 shares — an estimated $358K sold.

Cormorant Asset Management first reported a position in SRRA in Q3 2015 and held it in 3 quarters. The position peaked at $1.09M in Q3 2015. 44 funds tracked by Wall St. Rank hold SRRA as of Q2 2016.

  • Cormorant Asset Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • Cormorant Asset Management sold 1,329 Sierra Oncology, Inc. Common Stock shares in Q2 2016, an estimated $358K.
  • Cormorant Asset Management first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2015 and held it in 3 quarters.
  • Cormorant Asset Management's Sierra Oncology, Inc. Common Stock position peaked at $1.09M in Q3 2015.
  • 44 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q2 2016.

Based on Cormorant Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.